Sophia Genetics (NASDAQ:SOPH) just reported results for the second quarter of 2024.
- Sophia Genetics reported earnings per share of -23 cents. This was above the analyst estimate for EPS of -28 cents.
- The company reported revenue of $15.81 million.
- This was 9.15% worse than the analyst estimate for revenue of $17.40 million.